Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
16.05
+0.25 (1.58%)
Sep 17, 2025, 11:11 AM EDT - Market open
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $651.88 million as of September 17, 2025. Its market cap has decreased by -61.66% in one year.
Market Cap
651.88M
Enterprise Value
-30.54M
1-Year Change
-61.66%
Ranking
Category
Stock Price
$16.05
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $651.88M, an increase of 69.18%. That is a compound annual growth rate of 10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 641.72M | 0.08% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |